Our previous studies have shown that the expression level of NHE1 is directly correlated with tumor progression and inversely related to prognosis in hepatocellular carcinoma, and that NHE1 could be a potential therapeutic target for hepatocellular carcinoma [22,23]. Here, SLC9A1 is linked to neoplasm.